News

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in type 2 diabetes.

Precision treatment for rheumatoid arthritis is key. New research has used a cellular atlas to outline the variety of cellular causes, which may inform targeted, effective therapies.

New research from the University of Cincinnati found that daily strawberry consumption could help reduce the risk of dementia for certain middle-aged populations.

A new antifungal molecule, devised by tweaking the structure of prominent antifungal drug Amphotericin B, has the potential to harness the drug’s power against fungal infections while doing away with its toxicity.

The increased risk of blood clots caused by some hormonal contraceptives may drop within just 2–4 weeks of stopping their use, potentially informing how long to stop using hormonal contraceptives prior to major surgery, for example.

Huntington’s disease causes involuntary movements and dementia, has no cure, and is fatal. For the first time, UC Riverside scientists have shown they can slow its progression in flies and worms, opening the door to human treatments.

NIH study suggests the brain’s “salience network” is important for understanding substance use disorder, could be a future therapeutic target.

With the help of a new device, the In Situ Marine moleculE Logger, or I-SMEL, researchers at Station Marine d’Endoume, Marseille, have been able to collect sea sponge compounds with newfound ease.

A drug that prevents the accumulation of damaged mitochondria has shown promise for treating ALS in a mouse study.

Scientists have found that specially processed samples of willow bark extract have an antiviral effect which isn’t seen in already known medical compounds from willow bark, such as salicylic acid, the precursor to modern aspirin.